Global Cannabis
Khiron Enters the UK with Project Twenty21
In Q3/2020, Khiron began selling medical cannabis to patients in the UK through Project
Twenty21 & expanded medical cannabis doctor education in partnership with Medical
Cannabis Clinicians Society ("MCCS")
66.4 M
population
United Kingdom
US$ 1.3 Billion
TAM
Medical cannabis 2024 ¹
The Herald: Young mum is first in Scotland to be
prescribed cannabis
400,000
Medical cannabis patients
by 2024¹
Project Twenty21
• Europe's 1st & largest national medical cannabis registry (chronic
pain, epilepsy, PTSD, MS, substance abuse, anxiety). Goal to reach
20,000 patients by end of 2021
a to reach
1- Prohibition Partners - The UK Cannabis Report, January 2020
RC
PSYCH
ROYAL COLLEGE OF
PSYCHIATRISTS
KE
MCCS
An independent, clinician-led organization sharing guidance to
lead the medical cannabis conversation in the UK. The program
comprises access to Khiron's e-learning modules to help doctors
prescribe medical cannabis for priority conditions including
chronic pain, anxiety, cancer and epilepsy
11
7.3 Million
People use CBD in the UK
every year¹
THE BRITISH
PAIN SOCIETY
EXPERTISE WHERE IT MATTERS
KHIRON
LIFE SCIENCES CORP
Drug
Science
PLEA
For Quality of Life with
Medical Cannabis
MCS
Medical Cannabis
Clinicians SocietyView entire presentation